LASMIDTIME 50 (Lasmiditan 50 mg) – Steris Healthcare

What is LASMIDTIME 50 (Lasmiditan 50 mg) For?

LASMIDTIME 50 is built around Lasmiditan 50 mg, a lower-strength presentation of the first-in-class "ditan" molecule developed specifically for acute migraine attacks. It is commonly used as an initiating dose in patients starting Lasmiditan therapy for the first time, allowing physicians to assess individual tolerability before considering dose escalation. Like its higher-strength counterpart, it selectively targets 5-HT1F receptors rather than the vascular 5-HT1B receptors affected by triptans, making it a suitable choice for migraine patients with cardiovascular risk factors. Manufactured under WHO-GMP and ISO 9001:2018 certified conditions by Steris Healthcare, LASMIDTIME 50 offers dependable potency for consistent symptom relief during migraine episodes.

Why It's Important

Migraine attacks can be sudden, intense, and disabling, often accompanied by nausea, light sensitivity, and sound sensitivity that force patients to withdraw from work and daily responsibilities. Many patients, particularly the elderly or those with coexisting cardiovascular conditions, cannot safely use vasoconstrictive triptans. LASMIDTIME 50 is important because it offers a lower starting dose of a vascular-neutral therapy, giving physicians flexibility to titrate treatment based on patient response and tolerability, especially in those more sensitive to CNS side effects like dizziness or sedation.

Key Benefits of Lasmiditan 50 mg

What Are the Benefits?

  • Offers effective acute migraine relief at a lower starting dose
  • Non-vasoconstrictive mechanism, suitable for patients with cardiovascular contraindications to triptans
  • Useful for assessing individual tolerability before considering higher-strength therapy
  • Helps reduce migraine-associated nausea, photophobia, and phonophobia
  • Convenient oral tablet for at-home acute-attack management
  • Manufactured with strict quality assurance by Steris Healthcare

Mechanism of Action

Lasmiditan selectively binds to 5-HT1F serotonin receptors concentrated in the trigeminal ganglion and trigeminal nucleus caudalis, key sites in the migraine pain pathway. By activating these receptors, it suppresses the release of CGRP (calcitonin gene-related peptide) and other pro-inflammatory neuropeptides from trigeminal nerve terminals, reducing neurogenic inflammation and dampening pain signal transmission along the trigeminovascular system. Since 5-HT1F receptors are essentially absent from vascular smooth muscle, this relief occurs without the vasoconstriction associated with older triptan-class drugs, offering a distinct, heart-friendly mechanism for migraine control even at the lower 50 mg dose.

Side Effects

Common, generally mild and transient side effects of LASMIDTIME 50 may include:

  • Dizziness
  • Fatigue or drowsiness
  • Paresthesia (tingling sensation)
  • Nausea
  • Mild sedation

Serious Side Effects Of LASMIDTIME 50

Seek medical attention promptly if you experience:

  • Severe dizziness affecting your ability to drive or function
  • Signs of serotonin syndrome (agitation, rapid heartbeat, high fever, muscle rigidity)
  • Severe allergic reaction (rash, swelling, difficulty breathing)
  • Medication overuse headache with frequent or repeated use

Available Substitute For LASMIDTIME 50

Patients unable to access LASMIDTIME 50 may be prescribed other Lasmiditan 50 mg brands available in the market, based on their neurologist's advice, since formulation consistency and excipient quality can vary between manufacturers. Any brand substitution should be made under medical supervision, keeping in mind the drug's CNS depressant profile and related driving precautions.

Dosage Guidelines For LASMIDTIME 50

PopulationRecommended DoseFrequency
Adults (starting dose)50 mgSingle dose at onset of migraine
Adults (if needed)          May increase to 100 mg on physician's adviceSingle dose per attack
MaximumDo not exceed 200 mgPer 24-hour period

Tablets should be taken with or without food, at the first sign of a migraine attack, strictly as directed by a registered medical practitioner. Avoid driving or operating heavy machinery for at least 8 hours after each dose.

Precautions & Warnings

  • Avoid use in patients with known hypersensitivity to Lasmiditan
  • Causes CNS depression; do not drive or operate machinery for at least 8 hours post-dose
  • Avoid alcohol and other CNS depressants while on therapy
  • Use caution when combined with other serotonergic medications due to serotonin syndrome risk
  • Not recommended during pregnancy or breastfeeding unless advised by a physician
  • Limit frequency of use to avoid medication overuse headache
  • Keep out of reach of children

Conclusion

LASMIDTIME 50 (Lasmiditan 50 mg) from Steris Healthcare provides a lower-dose, vascular-neutral option for acute migraine relief, ideal as a starting therapy or for patients more sensitive to CNS side effects. Backed by WHO-GMP manufacturing standards and a targeted 5-HT1F mechanism, it stands as a reliable choice for neurologists tailoring migraine treatment to individual patient needs.

Comments

Post a Comment

Popular posts from this blog

Steris Healthcare: Committed to Quality Healthcare and Pharmaceutical Excellence

 Healthcare is one of the most significant sectors influencing the well-being of individuals and communities. As medical science advances, the demand for reliable pharmaceutical products continues to grow. Patients, healthcare professionals, and medical institutions all depend on high-quality medicines that meet strict standards of safety and effectiveness. Pharmaceutical companies play a vital role in ensuring these products are developed, manufactured, and delivered responsibly. Steris Healthcare is committed to supporting better healthcare by providing quality pharmaceutical products designed to improve patient outcomes. Guided by innovation, integrity, and continuous improvement, the company strives to meet the evolving needs of the healthcare industry while maintaining high standards of quality and customer satisfaction. A Vision for Better Healthcare Every successful healthcare organization begins with a clear vision. Steris Healthcare believes that quality medicines and de...
Read more

N-Acetyl L-Cysteine (NAC), Pine Bark Extract and Resveratrol Tablets for Daily Wellness

Image
  N-Acetyl L-Cysteine (NAC), Pine Bark Extract & Resveratrol Tablets: Ingredients and Health Benefits Today’s lifestyle in India has changed a lot. Long working hours, stress, pollution, processed food, and lack of physical activity are affecting overall health. Many people feel tired, low on energy, or struggle with metabolic and hormonal balance tablet . One of the main reasons behind this is oxidative stress. Oxidative stress happens when harmful molecules called free radicals damage the body’s cells. Over time, this may affect immunity, liver health, heart health, skin, and overall wellness.  STYLECYSTIN ENDO is a specially designed antioxidant tablet that contains N-Acetyl L-Cysteine (NAC), Pine Bark Extract, and Resveratrol . This powerful combination supports cellular protection, improves antioxidant levels, and promotes better internal balance. It is commonly recommended as supportive therapy in metabolic conditions, women’s health concerns, and lifestyle-related ...
Read more
Megestrol Acetate 160 mg: MAGRAL 160 Uses, Benefits & Safety MAGRAL 160 contains Megestrol Acetate 160 mg and is marketed by Steris Healthcare . Megestrol acetate is a synthetic progestin that is used in specific clinical situations, particularly for managing anorexia, cachexia, or significant unexplained weight loss associated with advanced cancer or AIDS , depending on the approved indication and medical judgment. It is a prescription medicine and should be used under the supervision of a qualified healthcare professional. Megestrol acetate is not a general-purpose appetite booster or routine weight-gain medicine. Before treatment, the underlying reason for poor appetite or weight loss should be evaluated. What is MAGRAL 160 For? MAGRAL 160 may be prescribed when significant appetite loss or involuntary weight loss occurs in certain serious medical conditions. Megestrol acetate can help increase appetite and may contribute to weight gain in appropriately selected patients. Th...
Read more